New frontiers in immunology science | UCB
UCB's Global Corporate Website

New frontiers in immunology science

Posted by
Eimear O'Brien, Brand Communications
05-Jun-2012
<iframe width="100%" height="244" frameborder="0" allowfullscreen="" src="http://www.youtube.com/embed/GmEq37S23MA"></iframe>

For all of us here at UCB, preparing for a major medical congress is a busy time but also gives us a chance to share what we’ve been doing to improve the lives of people living with serious diseases.

And, when it comes to medical congresses focused on rheumatology, they don’t come much bigger than the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology.

This year Berlin plays host to health professionals, scientists and companies committed to rheumatology. The annual EULAR congress provides a unique event for the exchange of scientific and clinical information.

There’s always a lot to be learned and we aim to make a strong contribution. Through sponsored abstracts and symposia, UCB will share research results in important disease areas including rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus.

We’ll have new data on a wide range of topics, demonstrating our continued commitment to rheumatology and people living with severe immunological conditions.

The EULAR Congress runs from June 6-9.

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.
15 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.